title: Does Y90 Radioembolization Prolong Overall Survival Compared With Chemoembolization in Patients With Hepatocellular Carcinoma?
authors.affiliation: Cancer Institute Eugène Marquis, Department of Nuclear Medicine and University of Rennes 1 and INSERM, U-991, Liver Metabolisms and Cancer, Rennes, France.
authors.forename: Etienne
authors.initials: E
authors.lastname: Garin
authors.affiliation: Cancer Institute Eugène Marquis, Department of Nuclear Medicine and University of Rennes 1 and INSERM, U-991, Liver Metabolisms and Cancer, Rennes, France.
authors.forename: Xavier
authors.initials: X
authors.lastname: Pallard
authors.affiliation: Cancer Institute Eugène Marquis, Department of Medical Oncology and University of Rennes 1 and Insern U991, Rennes, France.
authors.forename: Julien
authors.initials: J
authors.lastname: Edeline
mesh_terms: D006528:Carcinoma, Hepatocellular; D016461:Chemoembolization, Therapeutic; D004621:Embolization, Therapeutic; D006801:Humans; D008113:Liver Neoplasms; D016896:Treatment Outcome; D015021:Yttrium Radioisotopes
chemical_list: D015021:Yttrium Radioisotopes